| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Academic drug discovery in an age of research abundance, and the curious case of chemical screens toward drug repositioning
|
Datti, Alessandro
|
|
|
28 |
5 |
p.
|
artikel
|
| 2 |
API co-crystals – Trends in CMC-related aspects of pharmaceutical development beyond solubility
|
Becker, Axel
|
|
|
28 |
5 |
p.
|
artikel
|
| 3 |
A pipeline analysis of advanced therapy medicinal products
|
Wilkins, Georgina C.
|
|
|
28 |
5 |
p.
|
artikel
|
| 4 |
Aptamers and nanobodies as alternatives to antibodies for ligand-targeted drug delivery in cancer
|
Sanjanwala, Dhruv
|
|
|
28 |
5 |
p.
|
artikel
|
| 5 |
ATP-binding cassette efflux transporters and MDR in cancer
|
Pote, Manasi S.
|
|
|
28 |
5 |
p.
|
artikel
|
| 6 |
CIPDB: A biological structure databank for studying cation and π interactions
|
Yang, Jing-Fang
|
|
|
28 |
5 |
p.
|
artikel
|
| 7 |
Contents page
|
|
|
|
28 |
5 |
p.
|
artikel
|
| 8 |
Development of JmjC-domain-containing histone demethylase (KDM2-7) inhibitors for cancer therapy
|
Zhang, Lan
|
|
|
28 |
5 |
p.
|
artikel
|
| 9 |
Dysbiosis versus diabesity: Pathological signaling and promising therapeutic strategies
|
Sharma, Arun K.
|
|
|
28 |
5 |
p.
|
artikel
|
| 10 |
Exploring human CYP4 enzymes: Physiological roles, function in diseases and focus on inhibitors
|
Zhou, Manzhen
|
|
|
28 |
5 |
p.
|
artikel
|
| 11 |
Fatty acids as histone deacetylase inhibitors: Old biochemistry tales in a new life sciences town
|
Ediriweera, Meran Keshawa
|
|
|
28 |
5 |
p.
|
artikel
|
| 12 |
Global or local: The future of biotech
|
Tse, Vincent
|
|
|
28 |
5 |
p.
|
artikel
|
| 13 |
Harnessing personalized tailored medicines to digital-based data-enriched edible pharmaceuticals
|
Handa, Mayank
|
|
|
28 |
5 |
p.
|
artikel
|
| 14 |
Kinase inhibitors: Opportunities for small molecule anticancer immunotherapies
|
Safaroghli-Azar, Ava
|
|
|
28 |
5 |
p.
|
artikel
|
| 15 |
Microneedle array patches for allergen-specific immunotherapy
|
Paris, Juan L.
|
|
|
28 |
5 |
p.
|
artikel
|
| 16 |
Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics
|
Kalani, Komal
|
|
|
28 |
5 |
p.
|
artikel
|
| 17 |
Native mass spectrometry-directed drug discovery: Recent advances in investigating protein function and modulation
|
Fiorentino, Francesco
|
|
|
28 |
5 |
p.
|
artikel
|
| 18 |
Peptide modulators of cell migration: Overview, applications and future development
|
Gattringer, Jasmin
|
|
|
28 |
5 |
p.
|
artikel
|
| 19 |
Pharma’s Bio-AI revolution
|
Bentwich, Isaac
|
|
|
28 |
5 |
p.
|
artikel
|
| 20 |
Polymeric micelles as potent islet amyloid inhibitors: Current advances and future perspectives
|
Kaur, Jaskiran
|
|
|
28 |
5 |
p.
|
artikel
|
| 21 |
Potential of nanocarriers using ABC transporters for antimicrobial resistance
|
Amarnani, Ragini
|
|
|
28 |
5 |
p.
|
artikel
|
| 22 |
Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension
|
Ma, Binghao
|
|
|
28 |
5 |
p.
|
artikel
|
| 23 |
Randomized controlled trials do not always fit the purpose: A science-based response to Venetis and Mol’s editorial on biosimilars of follitropin alfa
|
de Mora, Fernando
|
|
|
28 |
5 |
p.
|
artikel
|
| 24 |
Recent progress in targeting KRAS mutant cancers with covalent G12C-specific inhibitors
|
Rathod, Lala S.
|
|
|
28 |
5 |
p.
|
artikel
|
| 25 |
Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective
|
Heikkinen, Inkatuuli
|
|
|
28 |
5 |
p.
|
artikel
|
| 26 |
Therapeutic strategies of small molecules in the microbiota–gut–brain axis for alcohol use disorder
|
Xie, Lushuang
|
|
|
28 |
5 |
p.
|
artikel
|
| 27 |
Tracing drugs from discovery to disposal
|
Omidian, Hossein
|
|
|
28 |
5 |
p.
|
artikel
|
Tijdschrift beschrijving